ArticleEchocardiography (Mount Kisco, N.Y.)2025
Does Left Atrial Size and E/e' Predict Outcomes in Hypertrophic Cardiomyopathy?
Article in Echocardiography (Mount Kisco, N.Y.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Does Left Atrial Size and E/e' Predict Outcomes in Hypertrophic Cardiomyopathy?Echocardiography (Mount Kisco, N.Y.) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAtrial arrhythmia is prevalent in patients with hypertrophic cardiomyopathy (HCM) and is prognostically deleterious. Catheter ablation (CA) has poor efficacy in HCM, making predictors of outcome valuable. Left atrial size is associated with morbidity and mortality, and E/e' has been proposed. The current study evaluates whether these predict non-paroxysmal atrial arrhythmia, interventions for atrial arrhythmia and all-cause mortality.
methods233 patients from the echocardiography database were included; patients with any mitral annular calcification were excluded. Medical records were reviewed for sample characteristics. Survival analysis was performed for left atrial diameter (LAD), left atrial volume index (LAVi, by area-length method), and E/e' with respect to endpoints, namely: non-paroxysmal atrial arrhythmia; atrial intervention (composite of CA and pace-and-ablate); and all-cause mortality. If LAD or LAVi were significant in multivariate analysis, ROC analysis and DeLong's test were performed to evaluate and compare their discriminative power.
resultsOver a median follow-up of 8 years (median age 53, 73% male), the overall prevalence of non-paroxysmal atrial arrhythmia was 31%. In multivariate models, LAVi was predictive of non-paroxysmal atrial arrhythmia and atrial intervention; LAD was only predictive of arrhythmia. LAVi demonstrated greater discriminative power for predicting atrial intervention. E/e' was not predictive of any outcome. No echocardiographic variable predicted death in multivariate analysis.
conclusionLAVi may have greater clinical utility compared to two-dimensional measurements like LAD. Future work should clarify which measures of left atrial size are most appropriate in clinical practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.